Prolonged transfusion-dependent temozolomide-induced thrombocytopaenia in glioblastoma: risk factors remain elusive
Authors
Ismail, NashwahPatel, Karan
Colaco, Rovel J
Borst, Gerben R
Milanovic, Dusan
McBain, Catherine A
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Ismail N, Patel K, Colaco R, Borst G, Milanovic D, McBain C. Prolonged Transfusion-Dependent Temozolomide-Induced Thrombocytopaenia in Glioblastoma: Risk Factors Remain Elusive. Neuro-oncology. 2022 Oct;24:23-. PubMed PMID: WOS:000864199800107.Journal
Neuro-OncologyDOI
10.1093/neuonc/noac200.105Type
Meetings and Proceedingsae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noac200.105